Authors:
COSTA A
LICITRA L
VENERONI S
DAIDONE MG
GRANDI C
CAVINA R
MOLINARI R
SILVESTRINI R
Citation: A. Costa et al., BIOLOGICAL MARKERS AS INDICATORS OF PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN ORAL-CAVITY CANCERS, International journal of cancer, 79(6), 1998, pp. 619-623
Authors:
LICITRA L
CAPRI G
FULFARO F
GRANDI C
TARENZI E
CAVINA R
GIANNI L
Citation: L. Licitra et al., BIWEEKLY PACLITAXEL AND CISPLATIN IN PATIENTS WITH ADVANCED HEAD AND NECK-CARCINOMA - A PHASE-II TRIAL, Annals of oncology, 8(11), 1997, pp. 1157-1158
Authors:
LICITRA L
CAVINA R
GRANDI C
DIPALMA S
GUZZO M
DEMICHELI R
MOLINARI R
Citation: L. Licitra et al., CISPLATIN, DOXORUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED SALIVARY-GLAND CARCINOMA - A PHASE-II TRIAL OF 22 PATIENTS, Annals of oncology, 7(6), 1996, pp. 640-642
Authors:
LICITRA L
FILIBERTI A
MENCAGLIA E
CAVINA R
TAMBURINI M
DEMICHELI R
GRANDI C
Citation: L. Licitra et al., QUALITY-OF-LIFE IN OPERABLE HEAD AND NECK-CANCER PATIENTS TREATED WITH PRIMARY CHEMOTHERAPY WITHIN A RANDOMIZED TRIAL, Quality of life research, 3(1), 1994, pp. 60-60